Zepbound (tirzepatide)
Weekly injection
A once-weekly injection, FDA-approved for chronic weight management.
See Zepbound pricesA supervised program built around FDA-approved GLP-1 medication, clear prices, and regular time with Helen.
We prescribe only FDA-approved medications, not compounded versions. Compounded semaglutide and tirzepatide aren't FDA-approved, so nobody has checked them for safety, effectiveness or quality before they're sold. Their strength and quality can vary, and their availability is uncertain. What we prescribe comes from the manufacturer, at the manufacturer's published price.
Your visits and your medication are paid for in different ways. Here's how each one works.
Billed to your insurance
Billed to your health insurance like any other office visit. Your usual copay or deductible applies.
If you don't have insurance, or would rather not use it, our self-pay rates are:
Paid to the manufacturer
In most cases paid out of pocket, directly to the manufacturer's self-pay program, because many plans don't cover GLP-1 medication for weight loss.
Yorkshire Rose doesn't sell the medication or add anything to its price. If your plan does cover it, we'll use your coverage.
See medication pricesThere's no separate program fee or membership, just your visits and your medication.
Medication is one tool, not the whole plan.
A proper conversation about your health history, your medications, what you've already tried, and what you'd like to change.
Bloodwork before you start, so there's a clear starting point and anything that needs attention first is found early. About the labs
You and Helen choose together, weighing your history, whether you'd prefer a pill or an injection, and what it will cost you.
The dose starts low and goes up in steps, giving your body time to adjust.
Check-ins to adjust the dose, manage side effects, and see how you're doing.
Eating enough protein, staying active, and protecting muscle while you lose weight are part of the plan from the start.
Eligibility depends on your BMI and your health history, and it's decided with Helen at your first visit. If medication isn't the right fit for you, she'll tell you plainly and explain why.
Some are weekly injections and some are daily tablets. Helen will go through which suits you.
Weekly injection
A once-weekly injection, FDA-approved for chronic weight management.
See Zepbound pricesWeekly injection
A once-weekly injection, FDA-approved for chronic weight management.
See Wegovy pen pricesWeekly injection
A higher-dose once-weekly Wegovy injection, FDA-approved for chronic weight management.
See Wegovy HD pricesDaily tablet
A once-daily tablet, FDA-approved for chronic weight management.
See Wegovy pill pricesDaily tablet
A once-daily tablet, FDA-approved for chronic weight management.
See Foundayo pricesOzempic and Mounjaro contain the same active ingredients as Wegovy and Zepbound. They're approved for type 2 diabetes, so using them for weight management is "off-label", which Helen will discuss with you. When you're paying out of pocket, the versions approved for weight management are often the same price or cheaper.
Weekly injection
A once-weekly injection, FDA-approved for type 2 diabetes.
Off-label for weight loss See Ozempic pricesWeekly injection
A once-weekly injection, FDA-approved for type 2 diabetes.
Contains the same active ingredient as Zepbound, which is usually the lower-cost option when paying out of pocket.
Off-label for weight lossSelf-pay pricing varies — we'll review your options at your visit.
Monthly self-pay prices, paid directly to the manufacturer's pharmacy program. Open any medication to see every dose.
| Medication | Starting dose | Maintenance | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-approved for weight management | ||||||||||||||
| Zepbound tirzepatide | $299/mo2.5 mg | $399–$699/mohigher doses$449/mo at 7.5 mg–15 mg if each refill is bought within 45 days of the last one. | ||||||||||||
See every Zepbound dose
|
||||||||||||||
| Wegovy pen semaglutide | $349/mo0.25 mg and 0.5 mgOffer: $199/mo for your first two fills as a new patient, through December 31, 2026. | $349/mohigher doses | ||||||||||||
See every Wegovy pen dose
|
||||||||||||||
| Wegovy HD semaglutide 7.2 mg | $399/mo7.2 mg | $399/moone dose | ||||||||||||
See every Wegovy HD dose
|
||||||||||||||
| Wegovy pill oral semaglutide | $149/mo1.5 mg | $199–$299/mohigher doses | ||||||||||||
See every Wegovy pill dose
Taken each morning on an empty stomach with a little plain water (no more than 4 ounces), 30 minutes before food. |
||||||||||||||
| Foundayo orforglipron | $149/mo0.8 mg | $199–$349/mohigher doses$299/mo at 14.5 mg–17.2 mg if each refill is bought within 45 days of the last one. | ||||||||||||
See every Foundayo dose
No fasting or water restrictions. |
||||||||||||||
| FDA-approved for type 2 diabetes (off-label for weight management) | ||||||||||||||
| Ozempic semaglutideOff-label for weight loss | $349/mo0.25 mg and 0.5 mgOffer: $199/mo for your first two fills as a new patient, through December 31, 2026. | $349–$499/mohigher doses | ||||||||||||
See every Ozempic dose
|
||||||||||||||
Prices last checked: September 25, 2026
We recommend the Weight & Metabolism panel as your baseline and monitoring panel: $280 on its own, or $345 together with the Foundation panel.
Some baseline labs may be covered by your insurance, and we'll bill insurance wherever it applies.
Baseline and monitoring labs can also be drawn at home for $75, paid out of pocket and performed by Labs at Home.
The most common side effects are digestive: nausea, diarrhea, vomiting, constipation, and stomach discomfort. Raising the dose gradually is meant to give your body time to adjust, and Helen will talk you through what to expect and when to get in touch.
These medications aren't used during pregnancy, or for anyone with a personal or family history of a type of thyroid cancer called medullary thyroid carcinoma, or with multiple endocrine neoplasia type 2 (MEN 2). Helen goes through your full history before recommending anything.
This page is general information, not medical advice. Whether a treatment is right for you, and whether you're eligible, is decided at a visit with Helen Hardy, APRN, FNP-BC.